Literature DB >> 21976064

Structural view of the regulatory subunit of aspartate kinase from Mycobacterium tuberculosis.

Qingzhu Yang1, Kun Yu, Liming Yan, Yuanyuan Li, Cheng Chen, Xuemei Li.   

Abstract

The aspartate kinase (AK) from Mycobacterium tuberculosis (Mtb) catalyzes the biosynthesis of aspartate family amino acids, including lysine, threonine, isoleucine and methionine. We determined the crystal structures of the regulatory subunit of aspartate kinase from Mtb alone (referred to as MtbAKβ) and in complex with threonine (referred to as MtbAKβ-Thr) at resolutions of 2.6 Å and 2.0 Å, respectively. MtbAKβ is composed of two perpendicular non-equivalent ACT domains [aspartate kinase, chorismate mutase, and TyrA (prephenate dehydrogenase)] per monomer. Each ACT domain contains two α helices and four antiparallel β strands. The structure of MtbAKβ shares high similarity with the regulatory subunit of the aspartate kinase from Corynebacterium glutamicum (referred to as CgAKβ), suggesting similar regulatory mechanisms. Biochemical assays in our study showed that MtbAK is inhibited by threonine. Based on crystal structure analysis, we discuss the regulatory mechanism of MtbAK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976064      PMCID: PMC4875266          DOI: 10.1007/s13238-011-1094-2

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  30 in total

1.  beta-Aspartokinase and beta-aspartyl phosphate.

Authors:  S BLACK; N G WRIGHT
Journal:  J Biol Chem       Date:  1955-03       Impact factor: 5.157

2.  A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria.

Authors:  Adeline Y Robin; David Cobessi; Gilles Curien; Mylène Robert-Genthon; Jean-Luc Ferrer; Renaud Dumas
Journal:  J Mol Biol       Date:  2010-04-14       Impact factor: 5.469

3.  Mechanism of concerted inhibition of alpha2beta2-type hetero-oligomeric aspartate kinase from Corynebacterium glutamicum.

Authors:  Ayako Yoshida; Takeo Tomita; Tomohisa Kuzuyama; Makoto Nishiyama
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

4.  The ACT domain family.

Authors:  D M Chipman; B Shaanan
Journal:  Curr Opin Struct Biol       Date:  2001-12       Impact factor: 6.809

5.  A novel organization of ACT domains in allosteric enzymes revealed by the crystal structure of Arabidopsis aspartate kinase.

Authors:  Corine Mas-Droux; Gilles Curien; Mylène Robert-Genthon; Mathieu Laurencin; Jean-Luc Ferrer; Renaud Dumas
Journal:  Plant Cell       Date:  2006-05-26       Impact factor: 11.277

6.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 7.  [Development of antituberculous drugs: current status and future prospects].

Authors:  Haruaki Tomioka; Kenji Namba
Journal:  Kekkaku       Date:  2006-12

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

Authors:  R D Fleischmann; D Alland; J A Eisen; L Carpenter; O White; J Peterson; R DeBoy; R Dodson; M Gwinn; D Haft; E Hickey; J F Kolonay; W C Nelson; L A Umayam; M Ermolaeva; S L Salzberg; A Delcher; T Utterback; J Weidman; H Khouri; J Gill; A Mikula; W Bishai; W R Jacobs; J C Venter; C M Fraser
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  6 in total

1.  Engineering allosteric control to an unregulated enzyme by transfer of a regulatory domain.

Authors:  Penelope J Cross; Timothy M Allison; Renwick C J Dobson; Geoffrey B Jameson; Emily J Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

2.  Structure analysis of the extracellular domain reveals disulfide bond forming-protein properties of Mycobacterium tuberculosis Rv2969c.

Authors:  Lu Wang; Jun Li; Xiangxi Wang; Wu Liu; Xuejun C Zhang; Xuemei Li; Zihe Rao
Journal:  Protein Cell       Date:  2013-07-05       Impact factor: 14.870

3.  Mechanism of the feedback-inhibition resistance in aspartate kinase of Corynebacterium pekinense: from experiment to MD simulations.

Authors:  Xiaoting Liu; Caijing Han; Li Fang; Zhanqing Fan; Yanan Wang; Xin Gao; Junhua Shi; Weihong Min
Journal:  RSC Adv       Date:  2020-12-22       Impact factor: 3.361

4.  Characterization of Aspartate Kinase from Corynebacterium pekinense and the Critical Site of Arg169.

Authors:  Weihong Min; Huiying Li; Hongmei Li; Chunlei Liu; Jingsheng Liu
Journal:  Int J Mol Sci       Date:  2015-11-27       Impact factor: 5.923

5.  Crystal structure of Clostridium acetobutylicum Aspartate kinase (CaAK): An important allosteric enzyme for amino acids production.

Authors:  Babu A Manjasetty; Mark R Chance; Stephen K Burley; Santosh Panjikar; Steven C Almo
Journal:  Biotechnol Rep (Amst)       Date:  2014-09-01

6.  Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection.

Authors:  Erik J Hasenoehrl; Dannah Rae Sajorda; Linda Berney-Meyer; Samantha Johnson; JoAnn M Tufariello; Tobias Fuhrer; Gregory M Cook; William R Jacobs; Michael Berney
Journal:  Nat Commun       Date:  2019-09-16       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.